ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryZurichQvanteq AG
Qvanteq AG Logo
Verified· 2 sources

Qvanteq AG

Summary

About the company

The core activity of Qvanteq AG is the development of biofunctional surfaces for medical devices and vascular stents, particularly with the goal of reducing thrombogenic effects and accelerating healing. The company focuses on developing technologies that prevent the activation of the blood coagulation cascade, thereby minimizing complications from medical devices and stents.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered8
Qstent technology
Bio-based surface technology for vascular medical devices with antithrombotic properties, reduced inflammatory response and rapid endothelialisation; coating-free and suitable for various implants.
Coronary stents (Qstent Coronary Stent System)
Coronary stent systems in various length and diameter combinations with Qstent surface technology; developed for reduced neointimal hyperplasia and improved endothelialisation.
Neurovascular stents, coils and flow diverters
Surface technology for intracranial stents, coils and flow diverters made of Nitinol and CoCr for the treatment of intracranial aneurysms.
Peripheral stents
Qstent technology for self-expanding, Nitinol-based peripheral stents for the treatment of occluded peripheral arteries or veins.
Other medical devices
Surface technologies for pumps, implants and accessories beyond stent-like devices; antithrombotic for materials or combined medical devices.
Consulting and development services
Support for development programmes and consulting mandates, including quality, Regulatory/MDR, validation, manufacturing, engineering, project management and regulatory approval planning.
In vitro thrombogenicity testing
Conducting and supporting thrombogenicity assessments of new materials, surfaces or complete devices using whole human blood and endothelial cell models.
Medical device development
Development and development support for medical devices, including planning and conducting animal studies as well as support for regulatory approval.
Comparisons

Qvanteq AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Qvanteq AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Qvanteq AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Technoparkstrasse 1
8005 Zurich

At a glance

Legal form
Corporation
UID
CHE-114.666.128
Founded
2009 · 17 years
Last commercial register change
December 9, 2025
Employees
1 to 10

Knowledge

No knowledge articles yet

Once Qvanteq AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

JS
JOTEC sales GmbH
Zurich
PS
PerkinElmer Scientific (Switzerland) GmbH
Bülach
IA
InSphero AG
Schlieren
MA
Medyria AG
Winterthur
VS
VP Sana Group AG
Zurich
SM
Schnell Medical Switzerland GmbH
Wädenswil
SM
Schnell Medical AG
Wädenswil
PM
Polymed Medical Center AG
Glattbrugg